News & Updates
Filter by Specialty:
Show Multimedia Only

Statins augment survival in prostate cancer patients on an ARPI
10 Oct 2025
byJairia Dela Cruz
Among prostate cancer patients receiving treatment with the androgen receptor pathway inhibitor (ARPI) apalutamide, those who also use statins appear to have longer overall survival, according to a study.
Statins augment survival in prostate cancer patients on an ARPI
10 Oct 2025
TRAILBLAZER-ALZ 6 updates support new donanemab dosing schedule for AD
10 Oct 2025
byAudrey Abella
In the 18-month results from the phase IIIb TRAILBLAZER-ALZ 6 trial, the newly recommended dosing schedule of donanemab results in a significant reduction in the incidence of amyloid-related imaging abnormalities with effusion/oedema (ARIA-E) compared with standard dosing in adults with early symptomatic Alzheimer’s disease (AD).